Surmodics Inc (SRDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 06-2020 | 03-2020 | 12-2019 | 09-2019 | 06-2019 | |
| Sales | 26,883 | 22,822 | 22,616 | 30,816 | 24,344 |
| Cost of Goods | 4,443 | 3,769 | 3,203 | 3,659 | 3,364 |
| Gross Profit | 22,440 | 19,053 | 19,413 | 27,157 | 20,980 |
| Operating Expenses | 21,719 | 19,978 | 19,882 | 23,941 | 20,327 |
| Operating Income | 1,164 | -156 | -266 | 3,875 | 1,017 |
| Interest Expense | 29 | 30 | 40 | 40 | 38 |
| Other Income | 76 | -299 | 204 | 283 | 227 |
| Pre-tax Income | 1,211 | -485 | -102 | 4,118 | 1,206 |
| Income Tax | -1,248 | -1,947 | -250 | 564 | -260 |
| Net Income Continuous | 2,459 | 1,462 | 148 | 3,554 | 1,466 |
| Net Income | $2,459 | $1,462 | $148 | $3,554 | $1,466 |
| EPS Basic Total Ops | 0.18 | 0.11 | 0.01 | 0.27 | 0.11 |
| EPS Basic Continuous Ops | 0.18 | 0.11 | 0.01 | 0.27 | 0.11 |
| EPS Diluted Total Ops | 0.18 | 0.11 | 0.01 | 0.26 | 0.11 |
| EPS Diluted Continuous Ops | 0.18 | 0.11 | 0.01 | 0.26 | 0.11 |
| EBITDA(a) | $2,954 | $1,640 | $1,538 | $5,984 | $2,904 |